STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
POAI PREDICTIVE ONCOLOGY INCORPORATED StockScouter® Report
5
StockScouter® Score
PREDICTIVE ONCOLOGY INCORPORATED, a micro cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year is holding steady compared to earnings growth in the past three years. Neutral
- The enterprise value-to-sales ratio is approximately in line with that of comparably-sized companies in the StockScouter universe. Neutral
Concerns
- Moving average analysis for POAI suggests weak price movement over the medium term. Negative
- Shares are being sold by financial institutions. Slightly negative for a small company like POAI
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
C
C
C
C